$ADXS Form 8-K


Form 8-K for ADVAXIS, INC.


Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

Item 7.01 Regulation FD Disclosure.A copy of the press release of Advaxis, Inc. (the “Company”) dated January 9, 2017 relating to the announcement discussed in Item 8.01 below is attached hereto as Exhibit 99.1.

The information furnished pursuant to this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.


Item 8.01 Other Events.On January 9, 2017, the Company announced its business outlook for 2017, including clinical development and expanding pipeline milestones.


Item 9.01. Financial Statements and Exhibits.(d) Exhibits.

The following exhibit is furnished as a part of this report

99.1 Press Release dated January 9, 2017.


Please enter your comment!
Please enter your name here